| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
89,559 |
84,009 |
$10.45M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
18,430 |
15,611 |
$5.69M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
34,853 |
31,250 |
$4.80M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
37,942 |
35,438 |
$4.53M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
37,002 |
33,421 |
$4.51M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16,591 |
14,678 |
$2.51M |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
8,756 |
828 |
$1.44M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,593 |
9,138 |
$1.17M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,480 |
3,944 |
$1.17M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,200 |
3,566 |
$1.14M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,363 |
6,882 |
$853K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,150 |
2,638 |
$710K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,346 |
2,553 |
$641K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,930 |
2,831 |
$632K |
| 62323 |
|
1,444 |
1,340 |
$499K |
| 80053 |
Comprehensive metabolic panel |
29,446 |
25,173 |
$496K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,660 |
1,420 |
$482K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,241 |
2,343 |
$466K |
| 64493 |
|
735 |
673 |
$393K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,057 |
2,844 |
$392K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,536 |
1,555 |
$390K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
9,936 |
9,078 |
$388K |
| G0378 |
Hospital observation service, per hour |
6,189 |
2,264 |
$371K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
45,987 |
39,790 |
$359K |
| 27096 |
|
1,401 |
1,249 |
$356K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
876 |
801 |
$341K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,212 |
1,040 |
$338K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,802 |
1,860 |
$315K |
| 81513 |
|
1,797 |
1,569 |
$279K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,059 |
987 |
$258K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
9,836 |
8,988 |
$249K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,174 |
670 |
$240K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,906 |
1,116 |
$230K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,705 |
1,028 |
$220K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
515 |
460 |
$218K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,291 |
1,207 |
$201K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
391 |
340 |
$186K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
11,817 |
11,005 |
$183K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,892 |
8,997 |
$180K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
11,619 |
10,324 |
$169K |
| 83655 |
|
4,932 |
4,675 |
$159K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
992 |
887 |
$159K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
60,101 |
50,605 |
$157K |
| 76801 |
|
1,039 |
941 |
$156K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
5,728 |
5,186 |
$152K |
| 80061 |
Lipid panel |
9,396 |
8,817 |
$152K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14,331 |
12,512 |
$143K |
| 20552 |
|
2,033 |
1,881 |
$135K |
| 76830 |
Ultrasound, transvaginal |
1,182 |
1,066 |
$127K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
381 |
300 |
$121K |
| 36415 |
Collection of venous blood by venipuncture |
57,528 |
49,508 |
$117K |
| 64494 |
|
933 |
673 |
$112K |
| 88142 |
|
5,051 |
4,697 |
$107K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
532 |
461 |
$95K |
| 64635 |
|
215 |
210 |
$94K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
403 |
369 |
$93K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
5,044 |
4,487 |
$93K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,071 |
969 |
$92K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,974 |
1,788 |
$91K |
| 94060 |
|
635 |
576 |
$90K |
| 71046 |
Radiologic examination, chest; 2 views |
10,738 |
9,899 |
$90K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,025 |
3,690 |
$88K |
| 97161 |
|
1,187 |
1,085 |
$87K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
547 |
472 |
$84K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,352 |
594 |
$82K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
621 |
528 |
$82K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
691 |
548 |
$81K |
| 71271 |
|
411 |
389 |
$81K |
| 87481 |
|
1,767 |
1,547 |
$80K |
| 12001 |
|
459 |
399 |
$79K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
2,151 |
1,907 |
$75K |
| 84439 |
|
3,057 |
2,768 |
$71K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
565 |
474 |
$70K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
350 |
329 |
$70K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
3,083 |
2,734 |
$70K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
141 |
106 |
$69K |
| 70496 |
|
276 |
239 |
$67K |
| 76642 |
|
490 |
452 |
$64K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
109 |
104 |
$60K |
| 96367 |
|
730 |
464 |
$60K |
| 93971 |
|
738 |
671 |
$59K |
| 93017 |
|
666 |
602 |
$59K |
| 87081 |
|
17,805 |
16,754 |
$55K |
| 80076 |
|
12,332 |
10,820 |
$54K |
| 97162 |
|
707 |
638 |
$54K |
| 82607 |
|
2,714 |
2,485 |
$53K |
| 64490 |
|
126 |
120 |
$52K |
| 84702 |
|
2,394 |
1,746 |
$52K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
300 |
283 |
$49K |
| 86592 |
|
1,558 |
1,434 |
$49K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
285 |
258 |
$49K |
| 80055 |
|
1,697 |
1,515 |
$49K |
| 85027 |
|
11,660 |
10,291 |
$48K |
| 10060 |
|
276 |
236 |
$47K |
| 76536 |
|
427 |
407 |
$47K |
| 87653 |
|
1,093 |
1,014 |
$47K |
| 82728 |
|
2,575 |
2,321 |
$46K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
176 |
153 |
$46K |
| 87077 |
|
6,169 |
5,399 |
$45K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
160 |
149 |
$41K |
| 86850 |
|
1,682 |
1,327 |
$40K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
20,562 |
18,169 |
$39K |
| 94726 |
|
558 |
503 |
$38K |
| 72131 |
|
596 |
521 |
$38K |
| 86140 |
|
2,139 |
1,881 |
$37K |
| 94729 |
|
543 |
490 |
$36K |
| 83970 |
|
1,260 |
1,165 |
$35K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,041 |
466 |
$34K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
66 |
52 |
$33K |
| 72100 |
|
869 |
790 |
$33K |
| 96415 |
|
120 |
91 |
$32K |
| 97165 |
|
523 |
469 |
$31K |
| 20553 |
|
360 |
325 |
$30K |
| 80069 |
|
1,809 |
1,666 |
$30K |
| 93970 |
|
239 |
215 |
$30K |
| 81001 |
|
38,829 |
34,864 |
$29K |
| 71250 |
|
379 |
351 |
$29K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
42 |
39 |
$28K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
24,733 |
21,174 |
$28K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,282 |
1,125 |
$28K |
| 73130 |
|
1,639 |
1,465 |
$28K |
| 74018 |
|
903 |
805 |
$28K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,975 |
1,788 |
$28K |
| 97010 |
|
801 |
341 |
$27K |
| 83735 |
|
9,794 |
8,089 |
$26K |
| 73630 |
|
1,855 |
1,674 |
$24K |
| 83721 |
|
1,714 |
1,603 |
$24K |
| 85014 |
|
2,576 |
2,339 |
$24K |
| H0012 |
Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient) |
78 |
25 |
$23K |
| 70486 |
|
351 |
310 |
$23K |
| 86900 |
|
1,809 |
1,439 |
$22K |
| 87480 |
|
1,290 |
1,139 |
$22K |
| 82950 |
|
1,684 |
1,573 |
$22K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,502 |
3,100 |
$21K |
| 73560 |
|
1,624 |
1,424 |
$20K |
| 64491 |
|
137 |
120 |
$19K |
| 12011 |
|
98 |
88 |
$19K |
| 84484 |
|
9,332 |
6,328 |
$19K |
| 86039 |
|
705 |
632 |
$19K |
| 76775 |
|
227 |
212 |
$19K |
| 72040 |
|
426 |
384 |
$19K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
27 |
26 |
$18K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,268 |
1,154 |
$18K |
| 76000 |
|
153 |
141 |
$17K |
| 87510 |
|
1,289 |
1,138 |
$17K |
| 87428 |
|
31,814 |
29,730 |
$17K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
208 |
194 |
$16K |
| 84460 |
|
1,661 |
1,543 |
$16K |
| 87186 |
|
3,427 |
2,976 |
$16K |
| 82043 |
|
2,058 |
1,926 |
$16K |
| 73030 |
|
1,114 |
990 |
$15K |
| 87340 |
|
726 |
669 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,867 |
5,045 |
$14K |
| 82570 |
|
1,620 |
1,463 |
$14K |
| 85652 |
|
2,887 |
2,549 |
$14K |
| 70491 |
|
56 |
52 |
$14K |
| 73110 |
|
1,002 |
881 |
$14K |
| 73610 |
|
1,466 |
1,258 |
$14K |
| 87070 |
|
1,194 |
1,047 |
$14K |
| 84481 |
|
853 |
791 |
$14K |
| 70498 |
|
275 |
241 |
$13K |
| 97116 |
|
421 |
213 |
$13K |
| 95811 |
|
27 |
26 |
$13K |
| 84466 |
|
1,449 |
1,314 |
$13K |
| 81161 |
|
109 |
87 |
$13K |
| 85018 |
|
2,619 |
2,377 |
$12K |
| 87522 |
Neg quan hep c or qual rna |
332 |
275 |
$12K |
| 90715 |
|
769 |
665 |
$12K |
| 76857 |
|
456 |
412 |
$12K |
| 64495 |
|
58 |
40 |
$11K |
| 82746 |
|
1,454 |
1,326 |
$11K |
| 80305 |
|
4,637 |
3,907 |
$11K |
| 84153 |
|
706 |
649 |
$11K |
| 80074 |
|
540 |
449 |
$11K |
| 80326 |
|
691 |
683 |
$11K |
| 29581 |
|
121 |
46 |
$11K |
| 83615 |
|
2,289 |
1,853 |
$10K |
| 11102 |
|
28 |
26 |
$10K |
| 83001 |
|
398 |
345 |
$10K |
| 73502 |
|
595 |
538 |
$10K |
| 97802 |
|
109 |
101 |
$10K |
| 84146 |
|
411 |
367 |
$10K |
| 83880 |
|
2,181 |
1,818 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
5,838 |
5,046 |
$10K |
| J1756 |
Injection, iron sucrose, 1 mg |
390 |
109 |
$10K |
| 12002 |
|
54 |
53 |
$10K |
| 93976 |
|
53 |
44 |
$9K |
| 88342 |
|
633 |
563 |
$9K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
546 |
455 |
$9K |
| 82248 |
|
2,572 |
2,339 |
$9K |
| 86901 |
|
1,809 |
1,439 |
$9K |
| 84403 |
|
420 |
380 |
$9K |
| 81200 |
|
109 |
87 |
$9K |
| 88112 |
|
228 |
205 |
$9K |
| 81329 |
|
379 |
300 |
$8K |
| 88307 |
|
62 |
52 |
$8K |
| 86803 |
|
157 |
150 |
$7K |
| 81255 |
|
109 |
87 |
$7K |
| 86431 |
|
470 |
435 |
$7K |
| 81251 |
|
109 |
87 |
$7K |
| 81290 |
|
109 |
87 |
$7K |
| 93270 |
|
40 |
39 |
$7K |
| 80346 |
|
983 |
972 |
$7K |
| 81330 |
|
109 |
87 |
$7K |
| 0352U |
|
481 |
462 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
33 |
32 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
17,137 |
14,174 |
$7K |
| 73080 |
|
513 |
471 |
$7K |
| 81209 |
|
109 |
87 |
$7K |
| 82784 |
|
445 |
386 |
$7K |
| 86235 |
|
368 |
318 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
263 |
253 |
$6K |
| 80361 |
|
979 |
968 |
$6K |
| 81260 |
|
109 |
87 |
$6K |
| 96376 |
|
2,679 |
1,503 |
$6K |
| 81242 |
|
109 |
87 |
$6K |
| 83690 |
|
10,993 |
9,540 |
$6K |
| 80365 |
|
931 |
920 |
$6K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
109 |
95 |
$6K |
| 83550 |
|
536 |
496 |
$6K |
| 97803 |
|
106 |
96 |
$6K |
| 81361 |
|
109 |
87 |
$6K |
| 80355 |
|
652 |
645 |
$6K |
| 86364 |
|
268 |
232 |
$6K |
| 80370 |
|
684 |
676 |
$6K |
| 80334 |
|
521 |
515 |
$6K |
| 80338 |
|
521 |
515 |
$6K |
| 80331 |
|
521 |
515 |
$6K |
| 80337 |
|
521 |
515 |
$6K |
| 85610 |
|
3,667 |
2,745 |
$6K |
| 86480 |
|
124 |
114 |
$6K |
| 80354 |
|
573 |
566 |
$5K |
| 80353 |
|
549 |
543 |
$5K |
| 36430 |
|
37 |
26 |
$5K |
| 82105 |
|
275 |
260 |
$5K |
| 86200 |
|
369 |
342 |
$5K |
| 80372 |
|
521 |
515 |
$5K |
| 80344 |
|
521 |
515 |
$5K |
| 80366 |
|
521 |
515 |
$5K |
| 80377 |
|
521 |
515 |
$5K |
| 80373 |
|
521 |
515 |
$5K |
| 80357 |
|
521 |
515 |
$5K |
| 80367 |
|
521 |
515 |
$5K |
| 80368 |
|
521 |
515 |
$5K |
| 80341 |
|
521 |
515 |
$5K |
| 88304 |
|
617 |
517 |
$5K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
95 |
94 |
$5K |
| 84550 |
|
908 |
784 |
$5K |
| 80364 |
|
844 |
835 |
$5K |
| 80360 |
|
521 |
515 |
$5K |
| 80348 |
|
521 |
515 |
$5K |
| 80359 |
|
521 |
515 |
$5K |
| 80358 |
|
521 |
515 |
$5K |
| 80371 |
|
521 |
515 |
$5K |
| 93880 |
|
55 |
53 |
$5K |
| 84156 |
|
1,083 |
944 |
$5K |
| 95816 |
|
29 |
28 |
$5K |
| 64636 |
|
298 |
210 |
$5K |
| 97163 |
|
67 |
58 |
$5K |
| 82077 |
|
3,952 |
3,276 |
$5K |
| 82670 |
|
147 |
128 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,507 |
3,401 |
$4K |
| 88341 |
|
75 |
64 |
$4K |
| 87205 |
|
1,053 |
920 |
$4K |
| 73590 |
|
390 |
335 |
$4K |
| 77062 |
|
141 |
128 |
$4K |
| 86255 |
|
252 |
216 |
$4K |
| 72128 |
|
202 |
176 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,706 |
9,140 |
$4K |
| 73221 |
|
31 |
28 |
$4K |
| 87660 |
|
573 |
478 |
$4K |
| 69209 |
|
27 |
25 |
$4K |
| 73700 |
|
27 |
25 |
$4K |
| J3490 |
Unclassified drugs |
2,799 |
2,372 |
$4K |
| 81003 |
|
8,832 |
8,301 |
$4K |
| 82565 |
|
429 |
365 |
$4K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
30 |
26 |
$4K |
| 80143 |
|
3,896 |
3,251 |
$4K |
| 77065 |
Tomosynthesis, mammo |
242 |
205 |
$4K |
| 72072 |
|
125 |
112 |
$4K |
| 82157 |
|
96 |
76 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
919 |
761 |
$4K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
123 |
115 |
$4K |
| 84436 |
|
189 |
169 |
$4K |
| 86258 |
|
103 |
86 |
$3K |
| 84100 |
|
649 |
505 |
$3K |
| 86762 |
|
230 |
222 |
$3K |
| 29125 |
|
112 |
90 |
$3K |
| 73090 |
|
300 |
262 |
$3K |
| 92526 |
|
39 |
12 |
$3K |
| 82550 |
|
556 |
451 |
$3K |
| J0897 |
Injection, denosumab, 1 mg |
12 |
12 |
$3K |
| 84450 |
|
354 |
313 |
$3K |
| 86160 |
|
220 |
193 |
$3K |
| 84145 |
|
1,227 |
964 |
$3K |
| 82677 |
|
74 |
74 |
$3K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
18 |
14 |
$3K |
| 87147 |
|
611 |
545 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
17,863 |
16,759 |
$3K |
| 81025 |
|
16,094 |
14,281 |
$3K |
| 93922 |
|
24 |
24 |
$2K |
| 86376 |
|
98 |
87 |
$2K |
| 17000 |
|
26 |
26 |
$2K |
| 80164 |
|
124 |
119 |
$2K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
446 |
384 |
$2K |
| 20610 |
|
16 |
13 |
$2K |
| 85055 |
|
113 |
102 |
$2K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
15 |
14 |
$2K |
| 82977 |
|
268 |
210 |
$2K |
| 85379 |
|
3,394 |
2,903 |
$2K |
| 83630 |
|
152 |
131 |
$2K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
132 |
119 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
28,003 |
23,869 |
$2K |
| 83540 |
|
214 |
192 |
$2K |
| 86308 |
|
347 |
301 |
$2K |
| 99215 |
Prolong outpt/office vis |
30 |
29 |
$2K |
| 80179 |
|
3,857 |
3,220 |
$2K |
| 76770 |
|
13 |
12 |
$2K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
34 |
24 |
$2K |
| 92523 |
|
23 |
20 |
$2K |
| 76882 |
|
32 |
27 |
$2K |
| 94618 |
|
41 |
41 |
$2K |
| 81243 |
|
109 |
87 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
168 |
127 |
$2K |
| 71101 |
|
229 |
210 |
$2K |
| 86787 |
|
45 |
40 |
$2K |
| 87046 |
|
99 |
87 |
$2K |
| 86618 |
|
202 |
132 |
$2K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
21 |
12 |
$2K |
| 77066 |
Tomosynthesis, mammo |
158 |
142 |
$2K |
| 86706 |
|
76 |
66 |
$2K |
| 83605 |
|
2,250 |
1,755 |
$1K |
| 85730 |
|
826 |
676 |
$1K |
| 86812 |
|
102 |
90 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,166 |
2,101 |
$1K |
| 80051 |
|
32 |
24 |
$1K |
| 81257 |
|
17 |
16 |
$1K |
| 87641 |
|
69 |
52 |
$1K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
15 |
14 |
$989.38 |
| 82247 |
|
95 |
63 |
$988.02 |
| 84703 |
|
345 |
297 |
$980.25 |
| 82947 |
|
92 |
82 |
$967.90 |
| 73140 |
|
227 |
199 |
$943.99 |
| 77080 |
|
15 |
15 |
$889.80 |
| 87427 |
|
95 |
83 |
$874.27 |
| 76870 |
|
53 |
44 |
$847.69 |
| 77061 |
|
43 |
38 |
$829.91 |
| 84112 |
|
25 |
25 |
$797.06 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,715 |
675 |
$788.60 |
| 80081 |
|
34 |
34 |
$754.42 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
6,991 |
5,980 |
$737.89 |
| 84132 |
|
185 |
133 |
$736.62 |
| 82803 |
|
1,788 |
1,409 |
$720.53 |
| 82040 |
|
57 |
50 |
$713.56 |
| 87529 |
|
32 |
25 |
$694.44 |
| 86920 |
|
16 |
14 |
$678.90 |
| 87040 |
|
640 |
440 |
$668.69 |
| 86696 |
|
34 |
28 |
$668.19 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,355 |
1,064 |
$616.03 |
| 87493 |
|
41 |
40 |
$602.82 |
| 84300 |
|
145 |
130 |
$601.47 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
2,076 |
1,566 |
$551.92 |
| 29105 |
|
12 |
12 |
$518.25 |
| 84165 |
|
80 |
71 |
$508.07 |
| 82140 |
|
37 |
26 |
$460.08 |
| 87507 |
|
15 |
15 |
$454.15 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,539 |
6,338 |
$452.96 |
| 73522 |
|
14 |
13 |
$449.51 |
| 86800 |
|
28 |
24 |
$432.82 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
3,473 |
3,107 |
$429.33 |
| J2704 |
Injection, propofol, 10 mg |
10,371 |
6,248 |
$386.93 |
| 86694 |
|
20 |
16 |
$385.41 |
| 83993 |
|
28 |
26 |
$374.33 |
| 00813 |
|
145 |
127 |
$366.02 |
| J7050 |
Infusion, normal saline solution, 250 cc |
5,196 |
2,940 |
$355.21 |
| 84155 |
|
45 |
36 |
$351.56 |
| 86336 |
|
62 |
62 |
$341.72 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14,573 |
11,486 |
$335.42 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,744 |
905 |
$306.84 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
507 |
352 |
$300.33 |
| 83727 |
|
17 |
12 |
$299.45 |
| 82951 |
|
13 |
13 |
$274.51 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
627 |
571 |
$271.39 |
| 80178 |
|
14 |
14 |
$264.27 |
| 87899 |
|
97 |
85 |
$235.37 |
| 86695 |
|
19 |
15 |
$231.21 |
| 84520 |
|
31 |
23 |
$229.92 |
| 73552 |
|
15 |
12 |
$227.47 |
| 84270 |
|
13 |
12 |
$222.41 |
| 85045 |
|
131 |
99 |
$222.33 |
| 82310 |
|
26 |
19 |
$220.34 |
| 73060 |
|
27 |
24 |
$217.48 |
| D0120 |
Periodic oral evaluation - established patient |
12 |
12 |
$215.16 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
949 |
619 |
$212.04 |
| 96368 |
|
32 |
24 |
$211.94 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
2,445 |
1,657 |
$196.48 |
| D1208 |
Topical application of fluoride, excluding varnish |
12 |
12 |
$189.00 |
| 84075 |
|
31 |
22 |
$182.11 |
| 87338 |
|
12 |
12 |
$181.15 |
| 82952 |
|
13 |
13 |
$177.73 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
521 |
378 |
$174.61 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,359 |
2,796 |
$170.79 |
| 84425 |
|
16 |
12 |
$161.89 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
312 |
190 |
$136.95 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,631 |
1,175 |
$132.38 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,544 |
1,041 |
$122.99 |
| 72170 |
|
26 |
24 |
$112.11 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
356 |
283 |
$111.93 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,553 |
3,340 |
$98.75 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,115 |
803 |
$96.03 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,536 |
2,019 |
$95.59 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
598 |
495 |
$77.83 |
| 87486 |
|
33 |
32 |
$77.60 |
| J2060 |
Injection, lorazepam, 2 mg |
756 |
571 |
$71.94 |
| 82150 |
|
232 |
222 |
$68.41 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,675 |
1,315 |
$57.38 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
110 |
76 |
$51.61 |
| J1644 |
Injection, heparin sodium, per 1000 units |
572 |
230 |
$50.95 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
2,325 |
2,081 |
$47.71 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,031 |
751 |
$44.62 |
| 87581 |
|
33 |
32 |
$38.80 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
35 |
27 |
$30.65 |
| J1940 |
Injection, furosemide, up to 20 mg |
396 |
195 |
$28.81 |
| J1630 |
Injection, haloperidol, up to 5 mg |
455 |
332 |
$26.44 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,183 |
898 |
$25.64 |
| J3411 |
Injection, thiamine hcl, 100 mg |
86 |
55 |
$23.22 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,736 |
1,237 |
$21.94 |
| J3480 |
Injection, potassium chloride, per 2 meq |
421 |
262 |
$19.71 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
19 |
17 |
$18.60 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
45 |
39 |
$18.43 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
64 |
48 |
$17.22 |
| 82962 |
|
380 |
344 |
$14.95 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,999 |
3,232 |
$13.43 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
106 |
86 |
$12.88 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
9,577 |
8,327 |
$12.00 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
45 |
38 |
$11.38 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
51 |
12 |
$9.40 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
3,707 |
3,334 |
$6.44 |
| 83986 |
|
14 |
14 |
$6.39 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
720 |
510 |
$4.17 |
| J7510 |
Prednisolone oral, per 5 mg |
83 |
71 |
$3.81 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
644 |
488 |
$3.31 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
403 |
284 |
$2.75 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
242 |
226 |
$2.34 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
211 |
146 |
$2.32 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
656 |
273 |
$0.62 |
| 88302 |
|
18 |
12 |
$0.00 |
| 01810 |
|
38 |
27 |
$0.00 |
| 77002 |
|
925 |
814 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
27 |
26 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
591 |
479 |
$0.00 |
| 15853 |
|
42 |
37 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
21 |
12 |
$0.00 |
| 00731 |
|
204 |
172 |
$0.00 |
| 00812 |
|
71 |
59 |
$0.00 |
| 86328 |
|
112 |
107 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
157 |
126 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
55 |
27 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
18 |
18 |
$0.00 |
| 82010 |
|
68 |
56 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
55 |
37 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
48 |
42 |
$0.00 |
| 00910 |
|
15 |
15 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
38 |
38 |
$0.00 |
| 00840 |
|
55 |
26 |
$0.00 |
| C1758 |
Catheter, ureteral |
15 |
12 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
541 |
474 |
$0.00 |
| C1769 |
Guide wire |
160 |
129 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
441 |
395 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
15 |
13 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
138 |
108 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
13 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
146 |
53 |
$0.00 |
| 00142 |
|
37 |
25 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
30 |
28 |
$0.00 |
| C2627 |
Catheter, suprapubic/cystoscopic |
134 |
110 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
90 |
42 |
$0.00 |
| 87807 |
|
13 |
12 |
$0.00 |